BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Interventional Spine, Inc. to Present the PerX360 System(TM) at the ISASS Annual Meeting in Barcelona, Spain


3/12/2012 10:29:41 AM

IRVINE, Calif., March 12, 2012 /PRNewswire/ -- Interventional Spine®, Inc. today announced that Dr. Rudolf Morgenstern, Director and Chief Surgeon of the Morgenstern Institute for Endoscopic Spine Surgery at Centro Medico Teknon in Barcelona, and Dr. David Greenwald from Flagler Brain and Spine Institute of St. Augustine, Florida will present the PerX360 System at the International Society for the Advancement of Spine Surgery (ISASS) Annual Meeting in Barcelona, Spain.

The PerX360 System is the first and only system in the world capable of providing surgeons the ability to perform a percutaneous interbody fusion via two incisions that are less than 15mm each for the treatment of lumbar discogenic pain. Dr. Morgenstern was a major contributor to the design of the PerX360 System and an early adopter of the technology. He implanted the first patient, soon after the system achieved CE certification in April of last year. His presentation will include nine months of patient data and details of the surgical technique he developed.

Dr. Greenwald will be presenting his initial patient data from his first implant of the Opticage in the United States performed on March 8, 2012.

To date, 17 patients have benefitted from the PerX360 technology with excellent clinical results and significant drops in pain scores.

The presentation will take place at the Palau de Congressos de Catalunya on Wednesday, March 21, from 1:00pm to 2:30pm, in Rooms E4-6. In addition, Interventional Spine will have booth #100 on the exhibit hall floor during the event.

Interventional Spine®, Inc. is a privately held company based in Irvine, California, that designs, develops and markets patented implantable devices for the spine that can be deployed via percutaneous techniques. Supported by the Company's unique product introduction systems, Interventional Spine's products provide benefits to patients, surgeons and hospitals alike. This system joins their current product offerings; the PERPOS® PLS System, the PERPOS® Percutaneous Cervical System, and the PDS System.

More information on the Company and its products can be found at:
www.i-spineinc.com and www.i-spineinc.com/perx360.php

FOR FURTHER INFORMATION CONTACT:
Walter A. Cuevas
949-472-0006

SOURCE Interventional Spine, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES